164 related articles for article (PubMed ID: 34713298)
1. Anterior gradient 2 regulates cancer progression in
Takabatake K; Konishi H; Arita T; Kataoka S; Shibamoto J; Furuke H; Takaki W; Shoda K; Shimizu H; Yamamoto Y; Komatsu S; Shiozaki A; Fujiwara H; Okamoto K; Otsuji E
Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34713298
[TBL] [Abstract][Full Text] [Related]
2. The circRNA circADAMTS6 promotes progression of ESCC and correlates with prognosis.
Bu J; Gu L; Liu X; Nan X; Zhang X; Meng L; Zheng Y; Liu F; Li J; Li Z; Sang M; Shan B
Sci Rep; 2022 Aug; 12(1):13757. PubMed ID: 35962061
[TBL] [Abstract][Full Text] [Related]
3. CircCNTNAP3-TP53-positive feedback loop suppresses malignant progression of esophageal squamous cell carcinoma.
Wang H; Song X; Wang Y; Yin X; Liang Y; Zhang T; Xu L; Jiang F; Dong G
Cell Death Dis; 2020 Nov; 11(11):1010. PubMed ID: 33239613
[TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation-mediated downregulation of tumor suppressor gene SEMA3B and lncRNA SEMA3B-AS1 correlates with progression and prognosis of esophageal squamous cell carcinoma.
Dong Z; Liang X; Wu X; Kang X; Guo Y; Shen S; Liang J; Guo W
Clin Exp Metastasis; 2019 Jun; 36(3):225-241. PubMed ID: 30915595
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
[No Abstract] [Full Text] [Related]
6. TP53 mediated miR-3647-5p prevents progression of cervical carcinoma by targeting AGR2.
Liu R; Qian M; Zhou T; Cui P
Cancer Med; 2019 Oct; 8(13):6095-6105. PubMed ID: 31436390
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA LSINCT5 is upregulated and promotes the progression of esophageal squamous cell carcinoma.
Jing L; Lin J; Zhao Y; Liu GJ; Liu YB; Feng L; Yang HY; Cui WX; Zhang XH
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5195-5205. PubMed ID: 31298370
[TBL] [Abstract][Full Text] [Related]
8. Mutant p53 activates hnRNPA2B1-AGAP1-mediated exosome formation to promote esophageal squamous cell carcinoma progression.
Feng R; Yin Y; Wei Y; Li Y; Li L; Zhu R; Yu X; Liu Y; Zhao Y; Liu Z
Cancer Lett; 2023 May; 562():216154. PubMed ID: 37030635
[TBL] [Abstract][Full Text] [Related]
9. SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness.
Piao L; Li H; Feng Y; Yang Z; Kim S; Xuan Y
Exp Cell Res; 2020 Apr; 389(1):111861. PubMed ID: 31981592
[TBL] [Abstract][Full Text] [Related]
10. Increased Numb protein expression predicts poor clinical outcomes in esophageal squamous cell carcinoma patients.
Liu Z; Luo C; Yang W; Wang K; Hu C; Zou J; Zhu H; Fu L; Nie J; Cheng C
Cancer Biol Ther; 2018 Jan; 19(1):34-41. PubMed ID: 28095111
[TBL] [Abstract][Full Text] [Related]
11. SEMA3B improves the survival of patients with esophageal squamous cell carcinoma by upregulating p53 and p21.
Tang H; Wu Y; Liu M; Qin Y; Wang H; Wang L; Li S; Zhu H; He Z; Luo J; Wang H; Wang Q; Luo S
Oncol Rep; 2016 Aug; 36(2):900-8. PubMed ID: 27349960
[TBL] [Abstract][Full Text] [Related]
12. Minichromosome maintenance 6 complex component identified by bioinformatics analysis and experimental validation in esophageal squamous cell carcinoma.
Li X; Ren Z; Xiong C; Geng J; Li Y; Liu C; Ren C; Liu H
Oncol Rep; 2020 Sep; 44(3):987-1002. PubMed ID: 32583000
[TBL] [Abstract][Full Text] [Related]
13. WISP3 suppresses ESCC progression by inhibiting the IGF-2-IGF1R-AKT signaling cascade.
Yu X; Mao R; Feng W; Zhao Y; Qin J; Yang Y; Wang A; Shi Z
Exp Cell Res; 2021 Dec; 409(1):112871. PubMed ID: 34672999
[TBL] [Abstract][Full Text] [Related]
14. PRIMA-1 induces p53-mediated apoptosis by upregulating Noxa in esophageal squamous cell carcinoma with TP53 missense mutation.
Furukawa H; Makino T; Yamasaki M; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
Cancer Sci; 2018 Feb; 109(2):412-421. PubMed ID: 29168598
[TBL] [Abstract][Full Text] [Related]
15. FAM3B promotes progression of oesophageal carcinoma via regulating the AKT-MDM2-p53 signalling axis and the epithelial-mesenchymal transition.
He SL; Wang WP; Yang YS; Li EM; Xu LY; Chen LQ
J Cell Mol Med; 2019 Feb; 23(2):1375-1385. PubMed ID: 30565387
[TBL] [Abstract][Full Text] [Related]
16. AGR2 expression as a predictive biomarker for therapy response in esophageal squamous cell carcinoma.
Lin CH; Chuang HN; Hsiao TH; Kumar VB; Hsu CH; Huang CY; Lee LW; Mao CL; Ko JL; Hsu CP
PLoS One; 2022; 17(11):e0276990. PubMed ID: 36327302
[TBL] [Abstract][Full Text] [Related]
17. Hypomethylation-Linked Activation of PLCE1 Impedes Autophagy and Promotes Tumorigenesis through MDM2-Mediated Ubiquitination and Destabilization of p53.
Chen Y; Xin H; Peng H; Shi Q; Li M; Yu J; Tian Y; Han X; Chen X; Zheng Y; Li J; Yang Z; Yang L; Hu J; Huang X; Liu Z; Huang X; Zhou H; Cui X; Li F
Cancer Res; 2020 Jun; 80(11):2175-2189. PubMed ID: 32066565
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA LINC01296 is associated with poor prognosis in ESCC and promotes ESCC cell proliferation, migration and invasion.
Wang B; Liang T; Li J
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4524-4531. PubMed ID: 30058683
[TBL] [Abstract][Full Text] [Related]
19. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling.
Zhang L; Zhou S; Guo E; Chen X; Yang J; Li X
Pflugers Arch; 2020 Aug; 472(8):1041-1049. PubMed ID: 32533239
[TBL] [Abstract][Full Text] [Related]
20. microRNA-377 acts as a suppressor in esophageal squamous cell carcinoma through CBX3-dependent P53/P21 pathway.
He Z; Chen J; Chen X; Wang H; Tang L; Han C
J Cell Physiol; 2021 Jan; 236(1):107-120. PubMed ID: 33459391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]